Invest in

Fighting Fat

11.2%
3.4%
0.2%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
11.2%
3.4%
0.2%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
53.3% Diabetes Care 11.6%
18.0% Merck & Company Inc. (new) MRK 33.1%
15.6% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 15.5%
12.6% Novo Nordisk A/S NVO 28.2%
2.7% Astrazeneca Plc ADR AZN 0.2%
2.3% Alkermes plc ALKS 59.2%
2.0% Integer Holdings Corporation ITGR --
40.3% Weight Management 59.1%
18.8% NutriSystem Inc NTRI 82.1%
9.8% MEDIFAST INC MED 56.8%
4.3% Weight Watchers International Inc WTW 9.9%
3.3% Nu Skin Enterprises Inc. (A) NUS 94.3%
2.0% USANA Health Sciences Inc. USNA 7.8%
1.4% Vitamin Shoppe Inc VSI 31.4%
0.6% GNC Holdings Inc. Class A GNC 71.6%
6.4% Weight Loss Drugs 9.2%
6.4% Arena Pharmaceuticals Inc. ARNA 9.2%

Quotes delayed 15 mins. Currently Feb 19, 2017 1:41:43 PM. Fields are marked with -- when data is unavailable.